CD4 and central nervous system cancer: ,12 (R)-2HG in the TME may impair production of IFNγ and IL-2 by CD4+ and CD8+ T cells as well as impacting myeloid cell populations, for example immunosuppressive glioma-associated macrophages generated due to altered tryptophan metabolism.23